The Enterprise Value as of December 2024 (TTM) for Sarepta Therapeutics, Inc. (SRPT) is 12.73B

According to Sarepta Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 12.73B. This represents a change of -2.01% compared to the average of 12.99B of the last 4 quarters.

Sarepta Therapeutics, Inc. (SRPT) Historical Enterprise Value (quarterly & annually)

How has SRPT Enterprise Value performed in the past?

The mean historical Enterprise Value of Sarepta Therapeutics, Inc. over the last ten years is 6.42B. The current 12.73B Enterprise Value has changed 19.73% with respect to the historical average. Over the past ten years (40 quarters), SRPT's Enterprise Value was at its highest in in the June 2024 quarter at 15.82B. The Enterprise Value was at its lowest in in the March 2015 quarter at 480.60M.

Sarepta Therapeutics, Inc. (SRPT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sarepta Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sarepta Therapeutics, Inc. (SRPT) Average Enterprise Value

How has SRPT Enterprise Value performed in the past?

The current Enterprise Value of Sarepta Therapeutics, Inc. (SRPT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sarepta Therapeutics, Inc. (SRPT) Enterprise Value vs. Peers

How is SRPT’s Enterprise Value compared to its peers?

Sarepta Therapeutics, Inc.’s Enterprise Value is greater than Reata Pharmaceuticals, Inc. (6.64B), greater than Mirati Therapeutics, Inc. (3.91B), greater than Krystal Biotech, Inc. (4.25B), greater than Intercept Pharmaceuticals, Inc. (915.81M), greater than PTC Therapeutics, Inc. (3.39B), greater than Iovance Biotherapeutics, Inc. (2.19B), greater than Madrigal Pharmaceuticals, Inc. (6.67B), greater than Viking Therapeutics, Inc. (4.67B), greater than Hepion Pharmaceuticals, Inc. (4.20M), less than Terns Pharmaceuticals, Inc. (0), greater than Akero Therapeutics, Inc. (234.86M), greater than null (1.70B),

Build a custom stock screener for Sarepta Therapeutics, Inc. (SRPT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sarepta Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sarepta Therapeutics, Inc. (SRPT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sarepta Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.